Point72 Asset Management »

Sarepta Therapeutics note 1.500% 11/1 shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Sarepta Therapeutics note 1.500% 11/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics note 1.500% 11/1 held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $20M 14M 1.43
2023-09-30 $16M 9.0M 1.77
2023-06-30 $15M 9.0M 1.70
2023-03-31 $17M 9.0M 1.94
2022-12-31 $17M 9.0M 1.87
2022-09-30 $15M 9.0M 1.66
2022-06-30 $22M 17M 1.27
2022-03-31 $22M 17M 1.31
2021-12-31 $14M 9.5M 1.47

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Dell Technologies CL C (DELL)
Union Pacific Corporation (UNP)
Boston Scientific Corporation (BSX)
Johnson Ctls Intl SHS (JCI)
NVIDIA Corporation (NVDA)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
CSX Corporation (CSX)
Honeywell International (HON)
Thermo Fisher Scientific (TMO)
Oracle Corporation (ORCL)
Western Digital (WDC)

View all positions for Point72 Asset Management

Top funds holding Sarepta Therapeutics note 1.500% 11/1

DLD Asset Management
Point72 Asset Management
D. E. Shaw & Co
CSS
Capstone Investment Advisors
Worth Venture Partners
Bank of America Corporation
Palisade Capital Management
Warberg Asset Management
Wolverine Asset Management
Bnp Paribas Arbitrage, Snc
Fox Hill Wealth Management
Virtus Investment Advisers
Royal Bank of Canada
Citigroup

View all funds holding Sarepta Therapeutics note 1.500% 11/1